List of Software Companies in Sweden - 7

ArgusEye provides innovative sensor systems based on nanoplasmonic detection for real-time monitoring of biological systems and processes.

Bionamic was founded by researchers to address the frustrating challenge of implementing digitalization in biopharma R&D. Our software platform can serve as a single source of truth for all your antibody related discovery and development data and offers an easy way to navigate it. We have put an incredible amount of thought and effort into making sure the data can be represented in a way that makes sense and helps to solve real problems.

We specialise in medical technology for digital pathology and aim to improve tissue diagnostics with our patented technology. With technology based on up-converted nanoparticles (UCNP), high-quality images are generated with increased contrast and decreased irrelevant background noise. These images shorten turnaround time and provide higher-quality data for analysis. Lumito is a spin-off from a research team at Lund University's Division of Atomic Physics and Laser Centre and is planning to launch its product SCIZYS for research laboratories initially.

Mentice, founded in 1999 and based in Sweden, is a leader in medical simulation solutions focused on image-guided interventional therapies (IGIT). The company has transitioned from providing endovascular simulators to offering comprehensive IGIT performance solutions aimed at enhancing clinical outcomes through advanced training and procedural optimization. Mentice is publicly traded on Nasdaq First North Growth Market under the ticker MNTC. The company provides a range of software and hardware simulation solutions designed to improve clinical performance in minimally invasive procedures. Key products include the VIST® series of haptic-enabled simulators for vascular procedures and MIST® systems for basic endovascular training. Mentice also offers portable platforms and integrated performance solutions that optimize workflow and assess clinician competency. The use of haptic feedback technology allows for realistic training in complex interventions. Mentice collaborates with global medical device companies and healthcare institutions, including notable partnerships with Terumo and Abbott. The company aims for significant annual sales growth and has expanded its geographic reach, including establishing an office in Chicago. Mentice is committed to addressing the demand for safer and more efficient minimally invasive procedures.

Qlucore makes it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. It is done by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. The easy to use tools empowers researchers, technicians and physicians to easily interpret and explore their datasets.

ADVANCING CANCER TREATMENT RaySearch is advancing cancer treatment through pioneering software. Software has unlimited potential, and we believe it is now the driving force for innovation in oncology. Medical science never stands still, and neither does RaySearch. We work in close cooperation with leading cancer centers to bring scientific advancements faster to the clinical world. Today, our solutions support thousands of clinics worldwide in the fight against cancer. And this is just the beginning.

At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve every aspect of modern clinical studies. Since 2003, Viedoc has united scientists and clinical trial professionals in a shared mission of pushing life-changing research forward. Our solution has been used to power thousands of studies, by collecting data from over a million patients and allowing it to flow smoothly across sites and countries. We take great pride in helping bridge the gap between patient and researcher – and, in the best of cases, between research and breakthrough.